Form 8-K - Current report:
SEC Accession No. 0001437749-24-023301
Filing Date
2024-07-24
Accepted
2024-07-24 06:40:14
Documents
78
Period of Report
2024-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20240722_8k.htm   iXBRL 8-K 86558
2 EXHIBIT 2.1 ex_702514.htm EX-2.1 732490
3 EXHIBIT 4.1 ex_701901.htm EX-4.1 94893
4 EXHIBIT 10.1 ex_701943.htm EX-10.1 226762
5 EXHIBIT 10.2 ex_701902.htm EX-10.2 64628
6 EXHIBIT 10.3 ex_701903.htm EX-10.3 58163
7 EXHIBIT 10.4 ex_701904.htm EX-10.4 48064
8 EXHIBIT 10.5 ex_702586.htm EX-10.5 475769
9 EXHIBIT 10.6 ex_701905.htm EX-10.6 178489
10 EXHIBIT 99.1 ex_702565.htm EX-99.1 45802
11 EXHIBIT 99.2 ex_702566.htm EX-99.2 10068
12 EXHIBIT 99.3 ex_702550.htm EX-99.3 21716
17 a01.jpg GRAPHIC 257740
18 a02.jpg GRAPHIC 156520
19 a03.jpg GRAPHIC 108445
20 a04.jpg GRAPHIC 127537
21 a05.jpg GRAPHIC 55968
22 a06.jpg GRAPHIC 42317
23 a07.jpg GRAPHIC 81211
24 a08.jpg GRAPHIC 58150
25 a09.jpg GRAPHIC 74040
26 a10.jpg GRAPHIC 64411
27 a11.jpg GRAPHIC 56739
28 a12.jpg GRAPHIC 46594
29 a13.jpg GRAPHIC 44761
30 a14.jpg GRAPHIC 57888
31 a15.jpg GRAPHIC 46788
32 a16.jpg GRAPHIC 81239
33 ex_702565img001.jpg GRAPHIC 2644
34 ex_702565img002.jpg GRAPHIC 2209
35 slide01.jpg GRAPHIC 43069
36 slide02.jpg GRAPHIC 131482
37 slide03.jpg GRAPHIC 64822
38 slide04.jpg GRAPHIC 42672
39 slide05.jpg GRAPHIC 78486
40 slide06.jpg GRAPHIC 35219
41 slide07.jpg GRAPHIC 48965
42 slide08.jpg GRAPHIC 57843
43 slide09.jpg GRAPHIC 74225
44 slide10.jpg GRAPHIC 58150
45 slide11.jpg GRAPHIC 42389
46 slide12.jpg GRAPHIC 74245
47 slide13.jpg GRAPHIC 54396
48 slide14.jpg GRAPHIC 51883
49 slide15.jpg GRAPHIC 64771
50 slide16.jpg GRAPHIC 57097
51 slide17.jpg GRAPHIC 35788
52 slide18.jpg GRAPHIC 62722
53 slide19.jpg GRAPHIC 56663
54 slide20.jpg GRAPHIC 68548
55 slide21.jpg GRAPHIC 67876
56 slide22.jpg GRAPHIC 46965
57 slide23.jpg GRAPHIC 71818
58 slide24.jpg GRAPHIC 45114
59 slide25.jpg GRAPHIC 58249
60 slide26.jpg GRAPHIC 56140
61 slide27.jpg GRAPHIC 67419
62 slide28.jpg GRAPHIC 57263
63 slide29.jpg GRAPHIC 44445
64 slide30.jpg GRAPHIC 58290
65 slide31.jpg GRAPHIC 47126
66 slide32.jpg GRAPHIC 32369
67 slide33.jpg GRAPHIC 75778
68 slide34.jpg GRAPHIC 39298
69 slide35.jpg GRAPHIC 78467
  Complete submission text file 0001437749-24-023301.txt   7265388

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA pirs-20240723.xsd EX-101.SCH 3409
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20240723_def.xml EX-101.DEF 11807
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20240723_lab.xml EX-101.LAB 15858
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20240723_pre.xml EX-101.PRE 12022
80 EXTRACTED XBRL INSTANCE DOCUMENT pirs20240722_8k_htm.xml XML 2944
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 241136057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)